Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease

• Päätekijät: Pengxin Dong (Tekijä), Hao Hu (Tekijä), Xiaodong Guan (Tekijä), Carolina Oi Lam Ung (Tekijä), Luwen Shi (Tekijä), Sheng Han (Tekijä), Shuwen Yu (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2018-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Complicated with the impact of aging population and urbanization, coronary heart disease (CHD) incurs more and more disease burdens in China. Salvianolate injection is a Chinese patent drug widely used for treating CHD in China. A series of studies have verified the efficacy of s...